Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

One Reason the Street Should Expect Big Things From Pfizer
Motley Fool
Wednesday, September 21, 2011 - 12:31pm
tags:
Pfizer
2 Drug Stocks To Buy Now
Seeking Alpha
Wednesday, September 21, 2011 - 12:29pm
tags:
Amgen, Pfizer
4-Star Stocks Poised to Pop: GlaxoSmithKline
Motley Fool
Wednesday, September 21, 2011 - 12:28pm
tags:
GSK
Pozen looks to fight off Anchen patent challenge
Bizjournals.com
Wednesday, September 21, 2011 - 12:28pm
tags:
Anchen, Pozen, patents, vivmo, arthritis, AstraZeneca
A Diet Pill Comeback? Orexigen Revives Its Drug
Pharmalot
Wednesday, September 21, 2011 - 9:26am
tags:
obesity, Orexigen, Contrave, FDA
Drug ETF Puts at Three-Year High as Pfizer Bears Climb: Options
Bloomberg
Wednesday, September 21, 2011 - 9:24am
tags:
ETFs, Pfizer
Pfizer Plans to Cut Spanish Workforce by 11%, Expansion Reports
Bloomberg
Wednesday, September 21, 2011 - 9:23am
tags:
Spain, Pfizer, layoffs
Celgene Higher on Revlimid Review Chatter
TheStreet.com
Tuesday, September 20, 2011 - 3:27pm
tags:
Celgene, Revlimid
Drug tycoon seeks review of girlfriend's death
Yahoo/AP
Tuesday, September 20, 2011 - 3:26pm
tags:
Medicis, Jonah Shacknai
The Truth About Vitaros
Seeking Alpha
Tuesday, September 20, 2011 - 3:24pm
tags:
Vitaros, Apricus Biosciences, erectile dysfunction
Betting on Gilead's New HIV Drug
Minyanville
Tuesday, September 20, 2011 - 3:23pm
tags:
HIV, Quad, Gilead
Obama plan hits pharma with rebates, pay-to-delay ban
Fierce Pharma
Tuesday, September 20, 2011 - 1:13pm
tags:
rebates, pay-for-delay, healthcare reform
Valeant Pharmaceuticals receives FTC requests for information on 2 pending acquisitions
Yahoo/AP
Tuesday, September 20, 2011 - 1:11pm
tags:
Valeant Pharmaceuticals, FTC, M&A, Ortho Dermatologics, Dermik
Industry pledges action on global NCD rise
CP Wire
Tuesday, September 20, 2011 - 1:02pm
tags:
cancer, chronic disease, cvd, diabetes, IFPMIA, pharma industry, International Federation of Pharmaceutical Manufacturers and Associations, lung, ncd
Is Forest Labs the Perfect Stock?
Motley Fool
Tuesday, September 20, 2011 - 12:58pm
tags:
Forest Labs
Merck speeding up layoffs of many US employees
Yahoo/AP
Tuesday, September 20, 2011 - 12:52pm
tags:
Merck, layoffs
Calls for action on unlicensed medicines
CP Wire
Tuesday, September 20, 2011 - 12:49pm
tags:
Europe, off-label, patients unlicensed
Lilly Steps Up Efforts to Improve Diversity in Clinical Trials
Yahoo
Tuesday, September 20, 2011 - 11:51am
tags:
Eli Lilly, diversity, clinical trials
Sanofi CEO says drug industry undervalued
Yahoo/Reuters
Tuesday, September 20, 2011 - 11:08am
tags:
Pharma CEOs, Sanofi, Chris Viehbacher
More Data on Vertex's Incivek
Yahoo/Zacks.com
Tuesday, September 20, 2011 - 11:07am
tags:
Vertex, Incivek, hepatitis C, Merck, JNJ, Victrelis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.